Related references
Note: Only part of the references are listed.Multiple Endocrine Neoplasia Type 1 (MEN1) 5′UTRDeletion, inMEN1Family, Decreases Menin Expression
Kreepa G. Kooblall et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Multiple Endocrine Neoplasia Type 1: Latest Insights
Maria Luisa Brandi et al.
ENDOCRINE REVIEWS (2021)
Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?
Amanda J. Seabrook et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Clinical aspects of multiple endocrine neoplasia type 1
Abdallah Al-Salameh et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Five patients with disorders of calcium metabolism presented with GCM2 gene variants
Alejandro Garcia-Castano et al.
SCIENTIFIC REPORTS (2021)
Whole exome sequencing in familial isolated primary hyperparathyroidism
F. Cetani et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
Whole genome sequencing of apparently mutation-negative MEN1 patients
Samuel Backman et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?
Lucie Coppin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene
Stephen J. Marx et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population
Ridge Dershem et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2020)
Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort
Sashi Mariathasan et al.
CLINICAL ENDOCRINOLOGY (2020)
Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1)
Poonam Dharmaraj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism
Hye Ryeon Choi et al.
Scientific Reports (2020)
Presenting features and molecular genetics of primary hyperparathyroidism in the paediatric population
Yasmine El Allali et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Multiple Endocrine Neoplasia Type 1 (MEN1) Phenocopy Due to a Cell Cycle Division 73 (CDC73) Variant
Kate E. Lines et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2020)
Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features
Anthony J. Gill et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Germline and somatic mosaicism in a family with multiple endocrine neoplasia type (MEN1) syndrome
Hanneke J. B. H. Beijers et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Diagnosis of mosaic mutations in the MEN1 gene by next generation sequencing
Lucie Coppin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
New Concepts About Familial Isolated Hyperparathyroidism
Stephen J. Marx
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors
Filomena Cetani et al.
ENDOCRINE-RELATED CANCER (2019)
Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases
Anja Frederiksen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Clinical genetic testing in endocrinology: Current concepts and contemporary challenges
Paul J. Newey
CLINICAL ENDOCRINOLOGY (2019)
Molecular and clinical insights from studies of calcium-sensing receptor mutations
Caroline M. Gorvin
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2019)
Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective
Stephen J. Marx et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas
Aaliyah Riccardi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Pediatric Parathyroid Carcinoma: A Case Report and Review of the Literature
Aditya Dutta et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors
Samuel A. Wells
ENDOCRINE-RELATED CANCER (2018)
Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms
Carole Guerin et al.
ENDOCRINE-RELATED CANCER (2018)
Advances in risk-oriented surgery for multiple endocrine neoplasia type 2
Andreas Machens et al.
ENDOCRINE-RELATED CANCER (2018)
Structure and function of RET in multiple endocrine neoplasia type 2
Ivan Plaza-Menacho
ENDOCRINE-RELATED CANCER (2018)
Heritable forms of primary hyperparathyroidism: a current perspective
Ronald A. DeLellis et al.
HISTOPATHOLOGY (2018)
Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss-of-Function G(11) Mutation
Caroline M. Gorvin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Familial hypocalciuric hypercalcemia and related disorders
Janet Y. Lee et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
65 YEARS OF THE DOUBLE HELIX Exploiting insights on the RET receptor for personalized cancer medicine
Lois M. Mulligan
ENDOCRINE-RELATED CANCER (2018)
Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias
Caroline M. Gorvin et al.
HUMAN MOLECULAR GENETICS (2018)
Insights into calcium-sensing receptor trafficking and biased signalling by studies of calcium homeostasis
Caroline M. Gorvin
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism
Mustapha El Lakis et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2018)
Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure
Mustapha El Lakis et al.
SURGERY (2018)
AP2 sigma Mutations Impair Calcium-Sensing Receptor Trafficking and Signaling, and Show an Endosomal Pathway to Spatially Direct G-Protein Selectivity
Caroline M. Gorvin et al.
CELL REPORTS (2018)
The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases
Fadil M. Hannan et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients
Francesca Marini et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma
Luis Cardoso et al.
HUMAN MUTATION (2017)
Hypercalcemic Disorders in Children
Victoria J. Stokes et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism
Karin van der Tuin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism
Bin Guan et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2017)
Utility of Population-Level DNA Sequence Data in the Diagnosis of Hereditary Endocrine Disease
Paul J. Newey et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2017)
Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure
Naris Nilubol et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Variability in penetrance of multiple endocrine neoplasia 2A with amino acid substitutions in RET codon 634
Andreas Machens et al.
CLINICAL ENDOCRINOLOGY (2016)
Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts
Bernhard Mayr et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism
Bin Guan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis
Fadil M. Hannan et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1
Wouter P. Kluijfhout et al.
WORLD JOURNAL OF SURGERY (2016)
Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt/Hedgehog/Notch pathways
Ippei Kikuchi et al.
NATURE COMMUNICATIONS (2016)
Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years
Paola Concolino et al.
CANCER GENETICS (2016)
Management of the Parathyroid Glands During Preventive Thyroidectomy in Patients With Multiple Endocrine Neoplasia Type 2
Jeffrey F. Moley et al.
ANNALS OF SURGERY (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Aetiology, Diagnosis and Surgical Treatment of Primary Hyperparathyroidism in Children: New Trends
Swethan Alagaratnam et al.
HORMONE RESEARCH IN PAEDIATRICS (2015)
Therapeutic Effectiveness of Screening for Multiple Endocrine Neoplasia Type 2A
Andreas Machens et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
MEN1 Disease Occurring Before 21 Years Old: A 160-Patient Cohort Study From the Groupe d'etude des Tumeurs Endocrines
P. Goudet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells et al.
THYROID (2015)
RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation
Nuria Valdes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling
Frederic Lamoliatte et al.
NATURE COMMUNICATIONS (2014)
Cytoplasmic parafibromin/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis
Jay-Hyun Jo et al.
NATURE COMMUNICATIONS (2014)
Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3
M. Andrew Nesbit et al.
NATURE GENETICS (2013)
Mutations Affecting G-Protein Subunit α11 in Hypercalcemia and Hypocalcemia
M. Andrew Nesbit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Menin: a scaffold protein that controls gene expression and cell signaling
Smita Matkar et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Whole-Exome Sequencing Studies of Nonhereditary (Sporadic) Parathyroid Adenomas
Paul J. Newey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Rajesh V. Thakker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism
Karin Frank-Raue et al.
CLINICAL ENDOCRINOLOGY (2011)
ROLE OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 MUTATIONAL ANALYSIS IN CLINICAL PRACTICE
Paul J. Newey et al.
ENDOCRINE PRACTICE (2011)
Cell Division Cycle Protein 73 Homolog (CDC73) Mutations in the Hyperparathyroidism-Jaw Tumor Syndrome (HPT-JT) and Parathyroid Tumors
Paul J. Newey et al.
HUMAN MUTATION (2010)
Parafibromin - functional insights
P. J. Newey et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Multiple endocrine neoplaslia type 1 (MEN 1): Analysis of 1336 mutations reported in the first decade following identification of the gene
Manuel C. Lemos et al.
HUMAN MUTATION (2008)
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome
JD Carpten et al.
NATURE GENETICS (2002)
Share Paper
